IHS Chemical Week

Regions :: Western Europe :: France

Lonza Signs Manufacturing Deal with French Biopharma Firm

11:49 PM MDT | July 14, 2009 | Deepti Ramesh

Lonza says it has signed an agreement with biopharmaceutical company LFB (Les Ulis, France) to manufacture a monoclonal anti-RhD antibody developed by LFB. The process developed by LFB will be transferred to Lonza which will provide manufacturing services for supporting the phase III clinical program, under the deal. Lonza will also support LFB in its regulatory submissions by providing appropriate documentation. Financial details of the agreement were not disclosed. LFB is the leading manufacturer of plasma-derived medicinal products in France and sixth...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa